Esophageal Cancer Patients
Conditions
Brief summary
This single-center, retrospective cohort study aimed to evaluate the short-term outcomes of enhanced recovery after surgery (ERAS) protocol in perioperative robotic-assisted McKeown esophagectomy (RAME) among esophageal cancer patients.
Interventions
PROCEDUREERAS protocol
Patients with esophageal cancer have undergone RAME using ERAS protocol and conventional management strategy
Sponsors
West China Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. first detected and endoscopically confirmed esophageal cancer; 2. preoperative evaluation showed no distant metastases and suitable for RAME; 3. preoperative clinical stage of I to III;
Exclusion criteria
1. patients had a history of thoracic or abdominal surgery; 2. patients were IV to VI in the American Society of Anesthesiologists (ASA) physical status classification system; 3. patients had other malignancies; 4. patients had missing clinical data
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| incidence of various postoperative complications | 2019-2022 | incidence of various postoperative complications characterized by postoperative outcome |
| time to liquid diet | 2019-2022 | time to liquid diet characterized by postoperative outcome |
| postoperative pain score | 2019-2022 | postoperative pain score characterized by postoperative outcome and was scored according to the numeric pain rating scale (NPRS) to assess the patient's pain on the first day after surgery. |
| duration of analgesic pump | 2019-2022 | duration of analgesic pump characterized by postoperative outcome |
| postoperative hospital stay | 2019-2022 | postoperative hospital stay characterized by postoperative outcome |
| ICU length of stay | 2019-2022 | ICU length of stay characterized by postoperative outcome |
| in-hospital mortality | 2019-2022 | in-hospital mortality characterized by postoperative outcome |
| time to first flatus | 2019-2022 | time to first flatus characterized by postoperative outcome |
| time to out-of-bed activity | 2019-2022 | time to out-of-bed activity characterized by postoperative outcome |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| preoperative anesthesia time | 2019-2022 | preoperative anesthesia time characterized by intraoperative outcome |
| operation time | 2019-2022 | operation time characterized by intraoperative outcome |
| blood loss | 2019-2022 | blood loss characterized by intraoperative outcome |
| conversion rate | 2019-2022 | conversion rate characterized by intraoperative outcome |
| radicality of surgery | 2019-2022 | R0 resection was defined as \> 1mm from all resection margins, R1 resection was defined as microscopic residual tumor, and R2 resection was defined as macroscopic residual tumor |
| postoperative chest drainage volume | 2019-2022 | postoperative chest drainage volume characterized by postoperative outcome |
Countries
China
Outcome results
None listed